Robert Jeanfreau, MD

Investigator
MedPharmics

Disclosure: Sanofi Pasteur (Individual(s) Involved: Self): Scientific Research Study Investigator

Presentation(s):

• 160 - Safety and Immunogenicity of Escalating Dose Formulations of High-dose Quadrivalent Influenza Vaccine in Children 6 Months Through < 18 Years of Age

  Oral Abstract